Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2024 investor letter. A copy of ...
Initiated IND-enabling studies for ABS-101 in FebruaryContinuing to advance ABS-201 and ABS-301 through preclinical studiesVANCOUVER, Wash. and ...
Asian shares hovered around 15-month highs on Tuesday and the dollar was firm ahead of highly anticipated U.S. inflation data ...
TEL AVIV, Israel and MIAMI, May 14, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the treatment of carotid artery disease (CAD) ...
JP Morgan Chase's investor day is scheduled for May 20, and some analysts adjusted their stock prices ahead of the annual ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...
The Company reported Basic and Diluted Earnings Per Share of fils 17 for Q1 2024 versus fils 34 for the same period in 2023 ...
The bounce has overlapped with a stronger-than-expected first-quarter reporting season for U.S. companies. With well over 80% ...
NVIDIA stock is displacing gold as a hedge against inflation as its shares have printed an impressive rally in the past ...
Seattle-based Zillow expects revenue from its residential business to be between $372 million to $382 million in the second ...
Alibaba reports earnings soon and many wonder if BABA stock is worth buying now. Read our earnings analysis to help decide.
DOYLESTOWN, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through ...